These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 4242420)

  • 1. [Hypoglycemia induced by N1-(n-butyl)-biguanide (Buformin) in animal experiments].
    Losert W; Loge O; Schillinger E
    Naunyn Schmiedebergs Arch Pharmakol; 1969; 264(3):275-7. PubMed ID: 4242420
    [No Abstract]   [Full Text] [Related]  

  • 2. [Animal experiments on the mode of action of biguanide. 2. Studies with 5-methoxyindole-2-carbonic acid].
    Losert W; Schillinger E; Kraaz W; Loge O; Jahn P
    Arzneimittelforschung; 1972 Aug; 22(8):1413-9. PubMed ID: 4678403
    [No Abstract]   [Full Text] [Related]  

  • 3. [Enhancement of the hypoglycemic action of insulin by buformin in rats].
    Schillinger E; Kraaz W; Loge O; Losert W
    Naunyn Schmiedebergs Arch Pharmakol; 1970; 266(4):437-8. PubMed ID: 4253861
    [No Abstract]   [Full Text] [Related]  

  • 4. [A phosphorylated biguanide: benfosformin (JAV 852). I. Hypoglycemic and antidiabetic properties].
    Loiseau G; Millischer R; Berthe G; Donadieu AM; Lohier P; Marquet JP
    Arzneimittelforschung; 1973 Nov; 23(11):1571-6. PubMed ID: 4801663
    [No Abstract]   [Full Text] [Related]  

  • 5. [Studies on the mode of action of biguanides in animals. 4. Studies on gamma-guanidinobutyramide and summary].
    Losert W; Schillinger E; Kraaz W; Loge O; Jahn P
    Arzneimittelforschung; 1972 Oct; 22(10):1752-61. PubMed ID: 4677069
    [No Abstract]   [Full Text] [Related]  

  • 6. [Extreme hypoglycemia during combined tolbutamide, n-1-butylbiguanide hydrochloride and chloramphenicol therapy].
    Ziegelasch HJ
    Z Gesamte Inn Med; 1972 Jan; 27(2):63-6. PubMed ID: 5022999
    [No Abstract]   [Full Text] [Related]  

  • 7. Increased responses of glucagon and glucose production to hypoglycemia with intraperitoneal versus subcutaneous insulin treatment.
    Wan CK; Giacca A; Matsuhisa M; El-Bahrani B; Lam L; Rodgers C; Shi ZQ
    Metabolism; 2000 Aug; 49(8):984-9. PubMed ID: 10954014
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of estrogen on hypoglycemia-induced neurological impairment in ovariectomized rats.
    Verma S; Srivastava RK; Sood S; Sharma S
    Methods Find Exp Clin Pharmacol; 2005; 27(6):405-9. PubMed ID: 16179959
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of McN-3495 [N-(1-methyl-2-pyrrolidinylidene)-N'-phenyl-1-pyrrolidinecarboximidamide], a new, orally effective, hypoglycemic agent, with the biguanides.
    Tutwiler GF; Bridi G
    Diabetes; 1978 Aug; 27(8):868-76. PubMed ID: 680413
    [No Abstract]   [Full Text] [Related]  

  • 10. [Progress in the therapy of diabetes].
    Raptis S; Rothenbuchner G; Pfeiffer EF
    Wien Med Wochenschr; 1971 Apr; 121(14):261-9. PubMed ID: 5559791
    [No Abstract]   [Full Text] [Related]  

  • 11. Oral agents for the treatment of type 2 diabetes mellitus: pharmacology, toxicity, and treatment.
    Harrigan RA; Nathan MS; Beattie P
    Ann Emerg Med; 2001 Jul; 38(1):68-78. PubMed ID: 11423816
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Comparative studies of the effect of N1-n-butylbiguanide hydrochloride (Buformin) and N1-n-butylbiguanide tosylate (Buformin retard)].
    Singer P; Thoelke H
    Z Gesamte Inn Med; 1973 Aug; 28(16):504-6. PubMed ID: 4767598
    [No Abstract]   [Full Text] [Related]  

  • 13. Treatment of reactive hypoglycemia with buformin.
    Sekso M; Solter M; Zjacić V; Cabrijan T
    Am J Clin Nutr; 1975 Nov; 28(11):1271-6. PubMed ID: 1190104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Acute biguanide poisoning: attempted suicide with butyl-biguanide].
    Gottesbüren H
    Fortschr Med; 1973 Apr; 91(10):407-9. PubMed ID: 4633661
    [No Abstract]   [Full Text] [Related]  

  • 15. [The pharmacological blockade of protein glycosylation in diabetes mellitus using sulfonylurea derivatives and biguanides].
    Lebedeva EA
    Eksp Klin Farmakol; 1996; 59(5):40-2. PubMed ID: 9026209
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological studies on n-butylbiguanide with special reference to hypoglycemic effect.
    Yoh YJ
    Acta Sch Med Univ Kioto; 1966 Jul; 39(3):138-56. PubMed ID: 5986764
    [No Abstract]   [Full Text] [Related]  

  • 17. Biguanide-induced mitochondrial dysfunction yields increased lactate production and cytotoxicity of aerobically-poised HepG2 cells and human hepatocytes in vitro.
    Dykens JA; Jamieson J; Marroquin L; Nadanaciva S; Billis PA; Will Y
    Toxicol Appl Pharmacol; 2008 Dec; 233(2):203-10. PubMed ID: 18817800
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Experience with the preparation n-butyl-biguanide ("Silubin")].
    Perinovic M; Kocic D
    Med Welt; 1967 Jul; 29():1692-3. PubMed ID: 5615769
    [No Abstract]   [Full Text] [Related]  

  • 19. Increased alanine uptake and lipid synthesis from alanine in isolated hepatocytes of Wistar-Kyoto fatty rats: an inhibitory effect of biguanides.
    Mori K; Nakamura J; Koh N; Sakakibara F; Hamada Y; Hara T; Komori T; Nakashima E; Naruse K; Takeuchi N; Hotta N
    Can J Physiol Pharmacol; 1997 Mar; 75(3):179-84. PubMed ID: 9164699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Causes and prevention of hypoglycemia due to glibenclamide].
    Gutsche H; Höpker W; Boenicke G
    Med Welt; 1969 Aug; 35():1876-8. PubMed ID: 5809860
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.